Learn how to enhance the effectiveness of safety risk communication in light of evolving regulatory expectations.

Explore the basics of drug safety and safety sciences in this seven module eLearning bundle.

Review the strategic and operational aspects of global risk management including key concepts, principles, and tools necessary to develop risk management programs.

Review how to design, develop, and manage a quality system related to your pharmacovigilance system to achieve quality and regulatory compliance.

Analyzing and interpreting safety data throughout product development.

Review confidence intervals, hypothesis testing, trial designs, and methods for establishing noninferiority and equivalence.

Learn how organizations structure their efforts and utilize their resources to improve the odds of successful development in this six module program.

Explore FDA's approach to regulation of combination products, the processes to streamline development of single entity, and aligning requirements between drugs and devices.

Learn the important considerations for implementing decentralized clinical trials and get the key take-aways from the recently issued FDA Draft Guidance on Decentralized Clinical Trials.

This online course provides information on planning a business outsourcing model, best practices for selecting and managing providers, and regulatory authority expectations for pharmacovigilance agreements.

Explore the fundamentals of why and how to incorporate patient focus and build organization-wide capabilities with this six module eLearning Program.

Discover the essential principles, regulatory insights, and compliance strategies for medical devices and combination products in this comprehensive on-demand training course.

Review the key benefits-risk assessment methods and how to incorporate the patient perspective.

Learn how to effectively plan, write, and communicate key safety information in pharmacovigilance documents while collaborating with safety professionals to ensure clear and impactful regulatory reporting.